A pterostilbene efficient delivery nanocomposite and its preparation method and application

By combining hyaluronic acid with sodium hyaluronate and phytosterol/octyldodecanol lauroyl glutamate to prepare nanocomplex, the problems of poor solubility and low stability of hyaluronic acid in cosmetics were solved, and the problem of hyaluronic acid in the past is improved. The utilization rate and antioxidant effect in the skin achieve better skin moisturizing and whitening effects.

CN117883303BActive Publication Date: 2024-11-12WANG SHUHE (WUHAN) BIOTECHNOLOGY ENGINEERING CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311739752.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-12-18
Publication Date
2024-11-12
Estimated Expiration
2043-12-18

Smart Images

  • Figure CN117883303B_ABST
    Figure CN117883303B_ABST
Patent Text Reader

Abstract

The present invention discloses a pterostilbene efficient delivery nanocomposite and its preparation method and application, and relates to the technical field of skin care product preparation. The present invention comprises the following raw materials in parts by weight: 10 to 30 parts of polyol, 10 to 30 parts of liquid lipid, 5 to 10 parts of phospholipid, 0.1 to 0.5 parts of cholesterol, 2 to 10 parts of emulsifier, 0.1 to 5 parts of pterostilbene, 0.1 to 2 parts of sodium hyaluronate, 0.1 to 2 parts of phytosterol / octyldodecanol lauroyl glutamate, and discloses its preparation method and application. The present invention utilizes nanocomposite technology to match pterostilbene with sodium hyaluronate and phytosterol / octyldodecanol lauroyl glutamate to prepare a nanocomposite with low irritation, moisturizing and antioxidant properties, which not only solves the problems of pterostilbene being easy to change color, poor solubility and easy crystallization in cosmetic formulas, but also improves the transdermal permeability of pterostilbene, and increases its utilization and efficacy as a whitening active ingredient in the body.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of skin care product preparation, and in particular to a pterostilbene efficient delivery nanocomposite and a preparation method and application thereof. Background Art

[0002] The skin is one of the largest organs in the human body. When the skin is frequently exposed to the external environment, it will inevitably be invaded by the outside world and produce free radicals. Since the body has its own antioxidant defense system, it has the function of scavenging free radicals. A healthy body maintains a dynamic balance between the production and removal of free radicals. However, when the human body is overexposed to sunlight radiation, environmental pollution and other environments, it will stimulate the production of excessive free radicals. In addition, human aging will cause the body's ability to scavenge free radicals to weaken, causing the body to suffer a large number of free radical invasions, which are manifested externally as dull, lusterless, sagging skin, and the production of spots and wrinkles.

[0003] Antioxidants can terminate the oxidation chain by combining with free radicals, thereby protecting the body from free radical damage. Currently, a large number of antioxidants have been widely used in cosmetics, such as vitamin C, vitamin E, coenzyme Q10, glutathione, EUK-134, carotenoids, resveratrol, etc.

[0004] Pterostilbene is an active ingredient derived from plants such as red sandalwood, blueberry, grape and palm tree. It is a methylated derivative of resveratrol and is known as the "second-generation resveratrol". It can effectively reduce cell aging and oxidative stress, and has multiple biological activities such as anti-inflammatory, antibacterial, whitening, and repair. Its bioavailability is higher and more stable than resveratrol.

[0005] However, as an excellent antioxidant, its application in cosmetics still has some problems:

[0006] 1. Poor solubility: Pterostilbene has extremely low solubility in most cosmetic matrix raw materials and is easy to crystallize, making it difficult to use.

[0007] 2. Instability: Pterostilbene is a polyphenolic substance with poor stability and is easily oxidized. It is prone to degradation and isomerization reactions when exposed to environmental conditions such as ultraviolet rays, oxygen, high temperature and pro-oxidants.

[0008] 3. Difficult to penetrate the skin: Active ingredients in skin care products find it difficult to penetrate the stratum corneum of the skin and reach the dermis to exert their effects.

[0009] The invention patent with publication number CN115040420A discloses a method for preparing pterostilbene liposomes. The invention uses liposome technology to solve the problems of easy discoloration, poor solubility, and easy crystallization of pterostilbene in cosmetic formulas; the invention patent with publication number CN115888880A discloses a liposome technology for simultaneously encapsulating pterostilbene and glabridin, and develops a synergistic nano-product with excellent whitening effect; the invention patent with publication number CN113208942B discloses a pterostilbene nanoemulsion formula, which improves the transdermal absorption efficiency of pterostilbene. However, most of the current technologies for nano-encapsulating pterostilbene are limited to a single active ingredient, and research on a nano-complex that simultaneously nano-encapsulates pterostilbene and phytosterol / octyldodecanol lauroyl glutamate and is supplemented with sodium hyaluronate as a matching component has not yet been reported. Summary of the invention

[0010] The invention provides a pterostilbene efficient delivery nanocomposite and a preparation method and application thereof, aiming to solve the problems existing in the above-mentioned background technology.

[0011] In order to achieve the above technical objectives, the present invention mainly adopts the following technical solutions:

[0012] In the first aspect, the present invention discloses a pterostilbene efficient delivery nanocomposite, comprising the following raw materials in parts by weight: 10 to 30 parts of polyol, 10 to 30 parts of liquid lipid, 5 to 10 parts of phospholipid, 0.1 to 0.5 parts of cholesterol, 2 to 10 parts of emulsifier, 0.1 to 5 parts of pterostilbene, 0.1 to 2 parts of sodium hyaluronate, and 0.1 to 2 parts of phytosterol / octyldodecanol lauroyl glutamate.

[0013] In a preferred embodiment of the present invention, the polyol is selected from one or more of sorbitol, glycerol, butylene glycol, dipropylene glycol, polyethylene glycol, 1,3-propanediol, and propylene glycol.

[0014] In a preferred embodiment of the present invention, the liquid lipid is selected from one or more of octyldodecyl alcohol, hexyldecanol, squalane, jojoba oil, caprylic capric triglyceride, isononyl isononanoate, isopropyl myristate, isopropyl palmitate, isopentyl laurate, and dimethicone.

[0015] In a preferred embodiment of the present invention, the phospholipid is selected from one or more of lecithin, soybean lecithin, hydrogenated lecithin, acetylated lecithin, phosphatidylcholine, phosphatidylglycerol, and hydrogenated egg phosphatidylcholine.

[0016] In a preferred embodiment of the present invention, the emulsifier is selected from one or more of PEG-15 lauryl glyceride, PEG-12 stearate, PEG-24 cholesterol ether, PEG-40 hydrogenated castor oil, sucrose stearate, and PEG-20 methyl glucose sesquistearate.

[0017] In a preferred embodiment of the present invention, the sodium hyaluronate is selected from one or more of oligomeric sodium hyaluronate, small molecule sodium hyaluronate, and sodium hyaluronate, and the molecular weight of the sodium hyaluronate is between 0.8 kDa and 1 MDa.

[0018] In a second aspect, the present invention discloses a method for preparing the pterostilbene efficient delivery nanocomposite as described in the first aspect, comprising the following steps:

[0019] S1: mixing liquid lipid, pterostilbene, phytosterol / octyldodecanol lauroyl glutamate, phospholipid and cholesterol to obtain a mixture A;

[0020] S2: adding an emulsifier to mixture A and stirring thoroughly to obtain mixture B;

[0021] S3: Mixing polyol, sodium hyaluronate and deionized water and stirring to obtain a mixture C;

[0022] S4: slowly adding mixture C into mixture B under heating conditions, quickly stirring and emulsifying to obtain mixture D;

[0023] S5: The mixture D is subjected to high-pressure microfluidization treatment, and then cooled to room temperature to obtain a pterostilbene efficient delivery nanocomposite.

[0024] In a preferred embodiment of the present invention, in step S1, before stirring, a preheating step is further included: preheating the liquid lipid, pterostilbene, phytosterol / octyldodecanol lauroyl glutamate, lecithin, and cholesterol at 50-70° C. for 10-15 minutes;

[0025] In step S2, the mixture is stirred at 50 to 70° C. and 500 to 800 rpm for uniform mixing;

[0026] In step S3, mixing and stirring at 45-50° C.

[0027] In step S4, the heating condition is 45-50° C., and the mixture is stirred rapidly and uniformly at a speed of 800-1200 rpm;

[0028] In step S5, the high-pressure microfluidization treatment conditions are: high-pressure microfluidization treatment at 0.1-1 MPa for 2-10 times.

[0029] In a preferred embodiment of the present invention, the particle size of the prepared nanocomposite particles is 10-100 nm.

[0030] In a third aspect, the present invention discloses a use of the pterostilbene efficient delivery nanocomposite as described in the first aspect in the preparation of skin care products or cosmetics.

[0031] Compared with the prior art, the present invention has the following beneficial effects:

[0032] The present invention utilizes nanocomposite technology to combine pterostilbene with sodium hyaluronate and phytosterol / octyldodecanol lauroyl glutamate to prepare a nanocomposite with low irritation, moisturizing properties and antioxidant properties. The nanocomposite not only solves the problems of easy discoloration, poor solubility and easy crystallization of pterostilbene in cosmetic formulas, but also improves the transdermal permeability of pterostilbene, thereby increasing its utilization and efficacy as a whitening active ingredient in a living body. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] Figure 1 This is a diagram showing the appearance changes of the stability investigation results provided in Example 1 of the present invention;

[0034] Figure 2 A human skin patch test diagram provided by the present invention;

[0035] Figure 3 A comparison chart of active substance retention and cumulative permeation in Example 1 and Comparative Example 2 provided by the present invention;

[0036] Figure 4 A comparison chart of skin firmness of each group provided by the present invention;

[0037] Figure 5 A comparison chart of skin glossiness of each group provided by the present invention;

[0038] Figure 6 This is a graph showing the test results of DPPH free radical scavenging rate of each group provided by the present invention. DETAILED DESCRIPTION

[0039] The present invention is further described below in conjunction with specific embodiments. The specific embodiments are for further describing the present invention in detail, but are not intended to limit the protection scope of the present invention.

[0040] Pterostilbene is an antioxidant with excellent performance, but it is difficult to be widely used in cosmetics because of its poor solubility and low stability. Sodium hyaluronate is a classic skin moisturizer. The present invention selects to use sodium hyaluronate raw materials with lower molecular weight (less than 1MDa). This type of sodium hyaluronate can resist the release of inflammatory factors and repair cell damage while reducing cell water loss, and has good soothing and repairing effects on the skin. Phytosterol / octyldodecanol lauroyl glutamate is a ceramide substitute. While long-term moisturizing and repairing skin damage, it also has the advantages of improving the skin feel of cosmetics and enhancing the emulsification effect of cosmetics.

[0041] The present invention unexpectedly found that the nanocomposite formed by combining sodium hyaluronate and phytosterol / octyldodecanol lauroyl glutamate as moisturizers with pterostilbene has good moisturizing and antioxidant properties, which helps to improve the bioavailability of pterostilbene. Therefore, the present invention provides a method for preparing a nanocomposite for efficient delivery of pterostilbene, which combines pterostilbene with sodium hyaluronate and phytosterol / octyldodecanol lauroyl glutamate for the first time and then performs nano-encapsulation, which can improve the bioavailability of pterostilbene from the following dimensions:

[0042] The phospholipid bilayer structure wall material improves the amphiphilicity of pterostilbene and effectively improves the solubility of pterostilbene in the cosmetic matrix.

[0043] The structure of the nanocomplex is similar to that of the cell membrane. According to the principle of similarity, it is easier to fuse with cells and has good biocompatibility, which can effectively increase its concentration in the targeted parts of the skin and improve its bioavailability.

[0044] After the nano-encapsulation treatment, the chance of pterostilbene contacting with the external environment (such as pH, oxygen, metal ions, etc.) is reduced, effectively avoiding the inactivation and degradation of pterostilbene caused by the external environment. At the same time, since the contact between pterostilbene and the external environment is isolated, the pterostilbene after the nano-encapsulation treatment has better compatibility and can be compounded with various cosmetic matrices, with a wider range of applications.

[0045] The following is a specific description through examples.

[0046] Example 1

[0047] A method for preparing a pterostilbene efficient delivery nanocomposite comprises the following steps:

[0048] S1: preheat 30 parts of caprylic capric triglyceride, 5 parts of pterostilbene, 2 parts of phytosterol / octyldodecanol lauroyl glutamate, 10 parts of hydrogenated lecithin, and 0.2 parts of cholesterol at 70°C for 10 minutes and stir evenly;

[0049] S2: Add 10 parts of PEG-40 hydrogenated castor oil to the liquid prepared in S1, and stir thoroughly at 70°C and 700 rpm;

[0050] S3: Mix 20 parts of glycerol, 2 parts of small molecule sodium hyaluronate (0.8 kDa), and 20.8 parts of deionized water at 50°C and stir evenly;

[0051] S4: slowly add the liquid prepared in S3 to the liquid prepared in S2 under heating conditions at 50°C, and stir quickly at a speed of about 1000 rpm to mix and emulsify;

[0052] S5: The liquid prepared in S4 was treated with high-pressure microfluidization for three times under the condition of 0.5 MPa, and cooled to room temperature to obtain the pterostilbene efficient delivery nanocomposite 1 of Example 1.

[0053] Example 2

[0054] A method for preparing a pterostilbene efficient delivery nanocomposite comprises the following steps:

[0055] S1: preheat 10 parts of caprylic capric triglyceride, 0.1 parts of pterostilbene, 0.1 parts of phytosterol / octyldodecanol lauroyl glutamate, 5 parts of hydrogenated lecithin, and 0.1 parts of cholesterol at 50°C for 10 minutes and stir evenly;

[0056] S2: Add 2 parts of PEG-40 hydrogenated castor oil to the liquid prepared in S1, and stir thoroughly at 500 rpm at 50°C;

[0057] S3: 10 parts of propylene glycol, 0.1 parts of sodium hyaluronate (50 kDa), and 73.6 parts of deionized water were mixed and stirred at 45°C;

[0058] S4: slowly add the liquid prepared in S3 to the liquid prepared in S2 under heating conditions at 50°C, and stir quickly at a speed of about 1000 rpm to mix and emulsify;

[0059] S5: The liquid prepared in S4 was treated with high-pressure microfluidization at 0.1 MPa for 5 times, and cooled to room temperature to obtain the pterostilbene efficient delivery nanocomposite 2 of Example 2.

[0060] Example 3

[0061] A method for preparing a pterostilbene efficient delivery nanocomposite comprises the following steps:

[0062] S1: preheat 20 parts of isononyl isononanoate, 2 parts of pterostilbene, 1 part of phytosterol / octyldodecanol lauroyl glutamate, 8 parts of soy lecithin, and 0.5 part of cholesterol at 60°C for 15 minutes and stir evenly;

[0063] S2: Add 2 parts of PEG-40 hydrogenated castor oil to the liquid prepared in S1, and stir thoroughly at 60°C and 500 rpm;

[0064] S3: 30 parts of propylene glycol, 0.1 parts of sodium hyaluronate (500 kDa), and 26.4 parts of deionized water were mixed and stirred at 45°C;

[0065] S4: slowly add the liquid prepared in S3 to the liquid prepared in S2 under heating conditions of 50°C, and stir quickly at a speed of about 800 rpm to mix and emulsify;

[0066] S5: The liquid prepared in S4 is treated with high-pressure microfluidization twice under the condition of 1 MPa, and cooled to room temperature to obtain the pterostilbene efficient delivery nanocomposite 3 of Example 3.

[0067] Example 4

[0068] A method for preparing a pterostilbene efficient delivery nanocomposite comprises the following steps:

[0069] S1: preheat 30 parts of octyldodecanol, 3 parts of pterostilbene, 1 part of phytosterol / octyldodecanol lauroyl glutamate, 5 parts of acetylated lecithin, and 0.3 parts of cholesterol at 70°C for 10 minutes and stir evenly;

[0070] S2: Add 5 parts of PEG-40 hydrogenated castor oil to the liquid prepared in S1, and stir thoroughly at 70°C and 500 rpm;

[0071] S3: Mix 20 parts of 1,3-butanediol, 0.2 parts of sodium hyaluronate (10 kDa), and 35.5 parts of deionized water at 45°C and stir evenly;

[0072] S4: slowly add the liquid prepared in S3 to the liquid prepared in S2 under heating conditions of 50°C, and stir quickly at a speed of about 800 rpm to mix and emulsify;

[0073] S5: The liquid prepared in S4 was treated with high-pressure microfluidization at 0.5 MPa for 4 times, and cooled to room temperature to obtain the pterostilbene efficient delivery nanocomposite 4 of Example 4.

[0074] Example 5

[0075] A method for preparing a pterostilbene efficient delivery nanocomposite comprises the following steps:

[0076] S1: preheat 10 parts of octyldodecanol, 2 parts of pterostilbene, 3 parts of phytosterol / octyldodecanol lauroyl glutamate, 8 parts of acetylated lecithin, and 0.3 parts of cholesterol at 70°C for 10 minutes and stir evenly;

[0077] S2: Add 5 parts of PEG-24 cholesteryl ether to the liquid prepared in S1, and stir thoroughly at 800 rpm at 70°C;

[0078] S3: Mix 30 parts of 1,3-butanediol, 0.5 parts of sodium hyaluronate (10 kDa), and 41.2 parts of deionized water at 45°C and stir evenly;

[0079] S4: slowly add the liquid prepared in S3 to the liquid prepared in S2 under heating conditions of 50°C, and stir quickly at a speed of about 800 rpm to mix and emulsify;

[0080] S5: The liquid prepared in S4 was treated with high-pressure microfluidization at 0.5 MPa for 4 times, and then cooled to room temperature to obtain the pterostilbene efficient delivery nanocomposite 5 of Example 5.

[0081] Comparative Example

[0082] Comparative Example 1 is substantially the same as Example 1, except that: in Comparative Example 1, pterostilbene, phytosterol / octyldodecanol lauroyl glutamate, and sodium hyaluronate are not added, but water is used instead.

[0083] Comparative Example 2 is substantially the same as Example 1, except that lecithin and emulsifier are not added in Comparative Example 2, but water is used instead.

[0084] The obtained comparative example 2 had an inhomogeneous liquid. After standing for 5 minutes, the liquid was separated into layers and sediment appeared at the bottom, indicating that the liquid did not have good stability.

[0085] Test example

[0086] 1. Stability

[0087] The samples prepared in Examples 1-5 were placed in sealed containers at room temperature, 4°C and 45°C for 4 weeks. The samples were checked for precipitation or stratification at room temperature in the initial state and after four weeks, and the sample retention rate was tested. The experimental results are shown in Table 1.

[0088] Table 1 shows that Examples 1-5 prepared by the present invention all exhibit good stability. After being placed at room temperature, 4°C and 45°C for 90 days, no agglomeration and stratification occurred, and no active ingredient leaked. The appearance of Example 1 is shown in FIG. Figure 1 As shown (all are partial sampling). Therefore, the emulsion provided by the present invention has good stability and can be stably compounded in the finished product formula.

[0089] Table 1 Stability test results of the embodiments

[0090]

[0091] The prepared Examples 1-5 were analyzed for particle size using a Malvern particle size analyzer (model: Zetasizer Pro). First, the samples were diluted 10-1000 times appropriately. The Examples 1-5 were diluted 10 times before testing. According to the preset parameters and program tests, the emulsion particle size range of Examples 1-5 was between 10-100 nm, which can be called nanoemulsion at this particle size. The transdermal performance of the nanoemulsion has obvious advantages, and its particle size distribution has almost no change after being stored under different conditions, indicating that its stability is excellent.

[0092] 2. Human safety test

[0093] The human safety test method refers to the human skin patch test method in Chapter 7, Section 2 of the "Technical Specifications for Safety of Cosmetics" (2015 edition) for testing the skin occluded patch test.

[0094] Test samples: The compositions of Examples 1-5 were added to a common emulsion external base to prepare test samples, wherein the composition accounted for 2% of the total mass of the emulsion. Meanwhile, the common emulsion external base was used as a blank group.

[0095] Selection of testers: Volunteers aged 18 to 60 who meet the test requirements are selected as test subjects. People with the following conditions cannot be used as test subjects: those who have used antihistamines in the past week or immunosuppressants in the past month; those who have used any anti-inflammatory drugs on the test site in the past two months; those who have inflammatory skin diseases that have not been cured clinically; insulin-dependent diabetes patients; patients with asthma or other chronic respiratory diseases being treated; those who have received anti-cancer chemotherapy in the past 6 months; patients with immunodeficiency or autoimmune diseases; breastfeeding or pregnant women; those who have undergone bilateral mastectomy and bilateral axillary lymph node resection; those whose skin test sites have scars, pigments, atrophy, port wine stains or other blemishes that affect the determination of the test results; those who participate in other clinical trial researchers; those with highly sensitive constitutions; non-voluntary participants or those who cannot complete the specified content according to the test requirements.

[0096] Test method: Select 30 suitable subjects, including 20 females and 10 males. Select qualified spot test equipment with an area not exceeding 50mm2 and a depth of about 1mm. Put the test sample into the small chamber of the spot tester, and the amount used is about 0.020-0.025g. Use hypoallergenic tape to stick the spot tester with the test sample on the curved side of the subject's forearm, and press it lightly with the palm of your hand to evenly stick it on the skin for 24 hours. Figure 2 As shown, the skin reaction was observed according to the standards in Table 2 30 minutes (after the indentation disappears), 24 hours and 48 hours after the test sample spot tester was removed, and the observation results were recorded. The results are shown in Table 3.

[0097] Table 2 Skin reaction grading standards for skin occlusive patch test

[0098]

[0099] Table 3 Patch test scores

[0100] sample 0.5h 24h 48h Blank group All are level 0 All are level 0 All are level 0 Example 1 All are level 0 All are level 0 All are level 0 Example 2 All are level 0 All are level 0 All are level 0 Example 3 All are level 0 All are level 0 All are level 0 Example 4 All are level 0 All are level 0 All are level 0 Example 5 All are level 0 All are level 0 All are level 0

[0101] It can be seen from the patch results in Table 3 that the compositions of Examples 1-5 all achieved the expected effects and all showed negative reactions, which indicated that the compositions were non-irritating and provided a certain safety basis for subsequent human skin experiments.

[0102] 3. Permeability and retention test

[0103] The vertical Franz diffusion cell method was used to study the in vitro release behavior of the nanocomplex prepared by the present invention. Using suckling pig skin as a carrier, it was fixed between the supply chamber and the receiving chamber of the Franz diffusion cell, and the diffusion cell was fixed in a transdermal absorption diffusion instrument. With the magnetic stirrer and the constant temperature water bath turned on, the emulsion prepared in Example 1 (diluted to 2%) was added to the skin surface in the chamber, and another group was added with Comparative Example 2. The active substance concentration was consistent with the test sample of Example 1, and transdermal experiments were carried out separately. Then, the cumulative penetration amount, retention amount and other values ​​after 24 hours were calculated. Then, the results were analyzed after the in vitro transdermal test. The results are as follows. Figure 3 shown.

[0104] Depend on Figure 3 The experimental results show that after 24 hours, the cumulative skin permeation and retention of the emulsion prepared in Example 1 are significantly increased compared with those of Comparative Example 2, which directly indicates that the emulsion prepared in the present invention has good transdermal permeability and skin retention capacity, which is more conducive to its efficacy.

[0105] 4. Human efficacy evaluation

[0106] Test subjects: 30 subjects (30-50 years old) with obvious fine lines or sagging skin on their faces, including 25 women and 5 men. The test was performed with half of the face as a double-blind control.

[0107] Test samples: 2% of the sample of Example 1 was added to the blank cream as test sample 1, 2% of the sample of Comparative Example 1 was added to the blank cream as test sample 2, and the blank cream was used as a control.

[0108] The dosage is 2mg / cm2 .

[0109] The weight percentages of the raw materials in the blank cream formula are: 20% sweet almond oil, 10% propylene glycol, 8% steareth-6, 1% sodium alginate, 0.2% EDTA-2Na, 0.9% phenoxyethanol, 0.1% ethylhexylglycerin, and the rest is deionized water.

[0110] Evaluation cycle: Test skin condition on the 14th and 28th days of use.

[0111] Evaluation dimensions: Subjects' skin elasticity and glossiness of the tested skin.

[0112] Evaluation method: Use Cutometer MPA580 to test skin elasticity and firmness. The larger the ΔQ3, the more obvious the improvement in skin firmness. Use Glossymeter GL200 to test skin elasticity and firmness. The larger the ΔDSC and ΔGloss values, the better the skin gloss.

[0113] Test results: Figure 4 , 5 As shown, after using the sample containing 0.5% of Example 1 for 28 consecutive days, it was clearly observed that the subject's skin became tighter and more elastic and the glossiness was significantly improved. However, the sample of Comparative Example 1 without adding active ingredients and the blank cream without adding the pterostilbene nanocomposite had no obvious improvement effect.

[0114] 5. DPPH free radical scavenging experiment

[0115] The in vitro antioxidant properties of the samples were evaluated by scavenging DPPH free radicals. The ethanol solution had a maximum absorption at a wavelength of 517nm and was purple. When free radical scavengers were present, they paired with their electrons, causing the ultraviolet absorption intensity to weaken or even disappear, and the degree of fading was proportional to the number of electrons it accepted. Therefore, the antioxidant activity of the samples could be evaluated by measuring the changes in absorbance.

[0116] The specific steps are as follows:

[0117] Take three PE tubes, add 4 ml of deionized water to one tube, and add 4 ml of the liquid of the embodiment and the blank example to each of the other two tubes, which are marked as 1, 2, and 3 respectively. Add 4 ml of DPPH solution to tubes 1 and 2 in turn, and add 4 ml of anhydrous ethanol to tube 3. Mix well, keep it away from light for 30 minutes, and measure its absorbance in turn at a wavelength of 517 nm using an ultraviolet spectrophotometer.

[0118] The scavenging rate calculation formula is: scavenging rate (%) = [1-(A2-A3) / A1]*100%, where A2 is the absorbance of the test solution scavenging free radicals; A3 is the absorbance of the test solution.

[0119] The calculated results are shown in Table 4 and Figure 6 As shown:

[0120] Table 4 DPPH free radical scavenging test results

[0121] Grouping DPPH free radical scavenging rate of test samples % Example 1 74.1±3.7% Example 2 80.4±4.0% Example 3 65.3±3.3% Example 4 78.2±3.9% Example 5 69.7±3.5% Comparative Example 1 5.1±0.3% Comparative Example 2 42.8±2.1%

[0122] Experimental results: From Table 4 and Figure 6 It can be seen that the nanocomposites obtained in Examples 1-5 of the present invention can effectively scavenge free radicals, while the nanocomposites in Comparative Example 1 without active ingredients such as pterostilbene have a very weak ability to scavenge free radicals. Comparative Example 2 lacks important components, resulting in poor overall DPPH free radical scavenging effect, indicating that the components in the nanocomposites have a synergistic effect.

[0123] The present invention creatively combines pterostilbene with sodium hyaluronate and phytosterol / octyldodecanol lauroyl glutamate to prepare a nanocomposite. On the one hand, since we have established a pterostilbene protection process, the characteristics of easy inactivation, difficult application and difficult absorption of pterostilbene are overcome, the bioavailability of pterostilbene is improved, and the antioxidant activity of pterostilbene is fully utilized; on the other hand, since sodium hyaluronate and phytosterol / octyldodecanol lauroyl glutamate are added in the present invention, the product has the characteristics of mild, low irritation and good skin adhesion, thereby improving the use experience of the product.

[0124] Finally, it should be noted that the above examples are only some specific embodiments of the present invention. Obviously, the present invention is not limited to the above embodiments, and there are many variations. All variations that can be directly derived or associated with the content disclosed by a person skilled in the art should be considered as the protection scope of the present invention.

Claims

1. A pterostilbene efficient delivery nanocomposite, It is characterized in that The invention is composed of the following raw materials in parts by weight: 10 parts of octyldodecanol, 2 parts of pterostilbene, 3 parts of phytosterol / octyldodecanol lauroyl glutamate, 8 parts of acetylated lecithin, 0.3 parts of cholesterol, 5 parts of PEG-24 cholesterol ether, 30 parts of 1,3-butylene glycol, 0.5 parts of sodium hyaluronate, and 41.2 parts of deionized water; The molecular weight of the sodium hyaluronate is 10 kDa; The initial particle size of the pterostilbene high-efficiency delivery nanocomposite is 20.5 nm.

2. A method for preparing the pterostilbene efficient delivery nanocomposite as claimed in claim 1, It is characterized in that The steps include: S1: the weight portions of octyldodecanol, pterostilbene, phytosterol / octyldodecanol lauroyl glutamate, acetylated lecithin and cholesterol are uniformly stirred to obtain a mixture A; S2: adding the weight portion of PEG-24 cholesteryl ether to mixture A, and stirring thoroughly to obtain mixture B; S3: mixing and stirring the weight portions of 1,3-butanediol, sodium hyaluronate and deionized water to obtain a mixture C; S4: slowly adding mixture C into mixture B under heating conditions, quickly stirring and emulsifying to obtain mixture D; S5: The mixture D is subjected to high-pressure microfluidization treatment, and then cooled to room temperature to obtain a pterostilbene efficient delivery nanocomposite.

3. The method for preparing the pterostilbene efficient delivery nanocomposite according to claim 2, It is characterized in that In step S1, before stirring, a preheating step is also included: Preheating octyldodecanol, pterostilbene, phytosterol / octyldodecanol lauroyl glutamate, acetylated lecithin, and cholesterol at 50-70° C. for 10-15 minutes; In step S2, the mixture is stirred at 50 to 70° C. and 500 to 800 rpm for uniform mixing; In step S3, mixing and stirring at 45-50° C. In step S4, the heating condition is 45-50°C, and the mixture is stirred rapidly and uniformly at a speed of 800-1200 rpm; In step S5, the high pressure microfluidization treatment conditions are: High pressure microfluidization treatment was performed 2-10 times at 0.1-1 MPa.

4. Use of the pterostilbene efficient delivery nanocomposite according to claim 1 in the preparation of skin care products or cosmetics.